These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 15789822)

  • 21. [Serious Adverse Drug Reaction and Their Preventability in the Elderly Over 65 Years].
    Kanagaratnam L; Abou Taam M; Heng M; De Boissieu P; Roux MP; Trenque T
    Therapie; 2015; 70(5):477-84. PubMed ID: 26223243
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Standardized assessment of adverse drug reactions: the method used in France. Special workshop--clinical.
    Begaud B
    Drug Inf J; 1984; 18(3-4):275-81. PubMed ID: 10268556
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Safety profile of etifoxine: A French pharmacovigilance survey.
    Cottin J; Gouraud A; Jean-Pastor MJ; Dautriche AD; Boulay C; Geniaux H; Auffret M; Bernard N; Descotes J; Vial T
    Fundam Clin Pharmacol; 2016 Apr; 30(2):147-52. PubMed ID: 26588183
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of patient reporting of adverse drug reactions to the UK 'Yellow Card Scheme': literature review, descriptive and qualitative analyses, and questionnaire surveys.
    Avery AJ; Anderson C; Bond CM; Fortnum H; Gifford A; Hannaford PC; Hazell L; Krska J; Lee AJ; McLernon DJ; Murphy E; Shakir S; Watson MC
    Health Technol Assess; 2011 May; 15(20):1-234, iii-iv. PubMed ID: 21545758
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Serious adverse drug reactions with tramadol reported to the French pharmacovigilance database between 2011 and 2015].
    Moulis F; Rousseau V; Abadie D; Masmoudi K; Micallef J; Vigier C; Pierre S; Dautriche A; Montastruc F; Montastruc JL
    Therapie; 2017 Dec; 72(6):615-624. PubMed ID: 28755832
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Post-marketing safety profile of avocado-soybean unsaponifiables].
    Olivier P; Montastruc JL;
    Presse Med; 2010 Oct; 39(10):e211-6. PubMed ID: 20937576
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pediatric pharmacovigilance in an institute of national importance: Journey has just begun.
    Sharma PK; Misra AK; Gupta N; Khera D; Gupta A; Khera P
    Indian J Pharmacol; 2017; 49(5):390-395. PubMed ID: 29515280
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adverse drug reactions in patients with Alzheimer's disease and related dementia in France: a national multicentre cross-sectional study.
    Laroche ML; Perault-Pochat MC; Ingrand I; Merle L; Kreft-Jais C; Castot-Villepelet A; Durrieu G; Gras V; Guy C; Jean-Pastor MJ; Jonville-Béra AP; Merlet-Chicoine I; Miremont-Salamé G; Nourhashemi F; Charmes JP;
    Pharmacoepidemiol Drug Saf; 2013 Sep; 22(9):952-60. PubMed ID: 23794320
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Update of the French drug reaction assessment method].
    ; Arimone Y; Bidault I; Dutertre JP; Gérardin M; Guy C; Haramburu F; Hillaire-Buys D; Meglio C; Penfornis C; Théophile H; Valnet-Rabier MB
    Therapie; 2011; 66(6):517-25. PubMed ID: 22186077
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A survey of spontaneous reporting of adverse drug reactions in 10 years of activity in a pharmacovigilance centre in Portugal.
    Marques J; Ribeiro-Vaz I; Pereira AC; Polónia J
    Int J Pharm Pract; 2014 Aug; 22(4):275-82. PubMed ID: 24188533
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Using a capture-recapture method to assess the frequency of adverse drug reactions in a French university hospital.
    Lugardon S; Desboeuf K; Fernet P; Montastruc JL; Lapeyre-Mestre M
    Br J Clin Pharmacol; 2006 Aug; 62(2):225-31. PubMed ID: 16842398
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Overview of adverse reactions to nefopam: an analysis of the French Pharmacovigilance database.
    Durrieu G; Olivier P; Bagheri H; Montastruc JL;
    Fundam Clin Pharmacol; 2007 Oct; 21(5):555-8. PubMed ID: 17868209
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Drug safety and big clinical data: Detection of drug-induced anaphylactic shock events.
    Bouzillé G; Osmont MN; Triquet L; Grabar N; Rochefort-Morel C; Chazard E; Polard E; Cuggia M
    J Eval Clin Pract; 2018 Jun; 24(3):536-544. PubMed ID: 29532572
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Pristinamycin/Vitamin k antagonists drug interaction: a French pharmacovigilance database study].
    Guiboux AL; Dautriche A; Rocher F; Bruel M; Sgro C;
    Therapie; 2014; 69(5):391-4. PubMed ID: 25047671
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An analysis of legal warnings after drug approval in Thailand.
    Sriphiromya P; Theeraroungchaisri A
    Regul Toxicol Pharmacol; 2015 Feb; 71(1):108-13. PubMed ID: 25445000
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of serious adverse drug reactions as cause of emergency department visit in children: a 5-years active pharmacovigilance study.
    Lombardi N; Crescioli G; Bettiol A; Marconi E; Vitiello A; Bonaiuti R; Calvani AM; Masi S; Lucenteforte E; Mugelli A; Giovannelli L; Vannacci A
    BMC Pharmacol Toxicol; 2018 Apr; 19(1):16. PubMed ID: 29661234
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adverse drug reactions in Nigerian children: a retrospective review of reports submitted to the Nigerian Pharmacovigilance Centre from 2005 to 2012.
    Obebi Cliff-Eribo K; Sammons H; Star K; Ralph Edwards I; Osakwe A; Choonara I
    Paediatr Int Child Health; 2016 Nov; 36(4):300-304. PubMed ID: 26384567
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Confounding Variables and the Performance of Triggers in Detecting Unreported Adverse Drug Reactions.
    Varallo FR; Dagli-Hernandez C; Pagotto C; de Nadai TR; Herdeiro MT; de Carvalho Mastroianni P
    Clin Ther; 2017 Apr; 39(4):686-696. PubMed ID: 27913030
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Prevalence of diabetes in france and drug use: study based on the French pharmacovigilance database].
    Berthet S; Grolleau S; Brefel-Courbon C; Montastruc JL; Lapeyre-Mestre M
    Therapie; 2007; 62(6):483-8. PubMed ID: 18316014
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A comprehensive intervention for adverse drug reactions identification and reporting in a Pediatric Emergency Department.
    Morales Ríos O; Jasso Gutiérrez L; Talavera JO; Téllez-Rojo MM; Olivar López V; Garduño Espinosa J; Muñoz Hernández O
    Int J Clin Pharm; 2016 Feb; 38(1):80-7. PubMed ID: 26499501
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.